Pharma and Healthcare Turn to Creative Communications to Improve Patient Outcomes
A growing number of organizations are recognizing the power of creative communications in conveying a medical product’s advantages or in [...]
PCORI Funding Cycle Now Open; Call for Healthy Aging, Telehealth in Chronic Disease, and Healthcare Equity Proposals
Patient-Centered Outcomes Research Institute (PCORI) has announced a third funding cycle. A wide range of research proposals is welcome, including [...]
Massive Bio Announces Partnership With Patient-Centered Group Self Care Catalysts and Veterans Prostate Cancer Awareness Non-Profit to Improve Clinical Trial Diversity and Oncology RWE
Massive Bio will partner with non-profit group Veterans Prostate Cancer Awareness (VPCa) and patient-centered organization Self-Care Catalysts to promote enrollment [...]
COVID-19 Pandemic is Hastening the Patient Financial Experience Trend
The patient financial experience (PFX) is a growing trend in healthcare, hastened by the ongoing COVID-19 pandemic. Patients are pushing [...]
Data Analytics Highlight Delayed Pediatric Care During COVID-19 Pandemic and Inform Solutions
The Ann & Robert Lurie Children’s Hospital used analytics to understand how the COVID-19 pandemic was impacting patient care. Analytic [...]
ISPOR Article Highlights Substantial Yet Forgotten Impact of Healthcare on Patient Caregivers
An article published in the May/June issue of ISPOR’s Value & Outcomes Spotlight highlights the burden of disease on patient [...]
Astellas US President Discusses Improving Medication Affordability, Patient-Centered Care, and Learning From COVID-19 Challenges
PhRMA board member and Astellas US President Mark Reisenauer shares his thoughts on improving the healthcare system in the United [...]
JMCP Article Highlights Impact of Patient Experience on Value Framework
A recent article, published in the Journal of Managed Care and Specialty Pharmacy (JMCP), discusses how to incorporate the patient [...]
Patient Engagement Strategies Include Core Compensation Principles
The International Society for Pharmacoeconomics and Outcomes Research recently published its May/July issue of its Value & Outcomes Spotlight journal [...]
Syneos Health Unveils Patient Voice Consortium to Improve R&D Pipeline
Syneos Health has announced the launch of its Patient Voice Consortium, intended to highlight the patient perspective throughout the drug [...]
OPEN Health Experts Discuss Healthcare Industry Trends Including Market Access Challenges, HEOR Insights, and RWE Focus; Greater Emphasis on Patient Voice Needed
HealthEconomics.Com welcomed CEO of Evidence and Access Dr. Jeff Anderson and Senior Director of Strategic Market Access Dr. Rosemary Jose [...]
Clarivate Executive Brief Discusses Using RWD to Understand the Patient Journey
An executive brief released by Clarivate details the data sources that allow various stakeholders to understand the patient journey. It [...]
Veradigm and Lash Group Partner to Improve Patient Access to Specialty Prescription Drugs
Data solution company Veradigm and patient support services company Lash Group of Amerisource Bergen have reached an agreement that will [...]
Tufts Medical Center and National Health Council Report New Partnership to Enhance Value Assessments
The National Health Council (NHC) and the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts [...]
Upcoming Webinar on Successfully Utilizing Data to Improve Patient Outcomes
Each facet of the patient experience generates a substantial amount of data. A webinar will discuss how such data can [...]
Will Patient RWD Improve Cardiovascular Disease Outcomes?
Amgen and Datos Health have partnered to explore how RWD (real world data) can improve outcomes for heart disease patients. Using [...]
New eBook on Improving Patient-Centered Healthcare Using RWD
A new eBook offered by Optum discusses when it’s appropriate to use RWD (real world data) to improve healthcare outcomes. [...]
The Patient Side of Successful Drug Development
More and more, patient opinions are being considered when it comes to designing effective therapeutics and testing their efficacy. A [...]
New Report by Patient Coalition on Substandard Healthcare Plans Resulting in Patient Cost Burden
A coalition of 30 patient organizations advocating for healthcare access for patients with preexisting health conditions has released a new [...]
Understanding ICER’s New Life Years Metric
ICER (the Institute for Clinical and Economic Review) revealed a new metric in 2018: evLYG (equal value of life years [...]
Comparing ICER and IVI in Shifting Value-Based Reimbursement Landscape
The US healthcare system is transitioning from a volume- to a value-based reimbursement payment structure. Assigning value continues to be [...]
ReimbursementCodes Offers Payers a Solution to Rising Drug Prices, Report Details 129% Increase in Price of 9 Prescription Drugs
A new report reveals that the Average Wholesale Price of nine prescription drugs rose by 129% between 2010 and 2016, [...]
How Will Emphasis on Patient Centricity and ICER Influence Payer Decisions?
The 21st Century Cures Act, as well as FDA guidelines, are putting a spotlight on patient centricity—from drug development to [...]
Webinar on Providing Meaningful Price Transparency Information
In order to comply with recent rulings, many organizations are sharing large amounts of data. However, not all data is [...]
Changes for BresMed and Cello
In 2020, private equity firm Arsenal Capital Partners acquired BresMed and Cello, two independent biopharma companies. Now, BresMed and Cello [...]